Navigating the internet can be challenging and confusing. Presenters Vera Granikov, PhD Candidate and Virginie Paquet, Health Librarian review best practices for searching, critically evaluating, and using or sharing health […]

A recently released Canadian research study confirms what has been shown in past preliminary studies; – inflammation of the eye as a possible side effect of bisphosphonate therapy is very […]

Jack Hirsh Award Rick Adachi MD, FRCPC The McMaster Academic and Education Department of Medicine Awards review committee have selected an outstanding group of individuals for the 2020-2021 academic year. […]

There has been recent media coverage concerning a rare atypical femoral fracture that may be a side effect of denosumab (Prolia), an osteoporosis medication manufactured by Amgen. Osteoporosis Canada’s Scientific […]

In 2008 the results of a small study were published reporting on the use of choline stabilized orthosilicic acid a form of silicon, or placebo in 184 women with low […]

Vitamin D plays a significant role in building and maintaining healthy bones. In light of the current COVID-19 pandemic, the effects of vitamin D on the immune system are being […]

Strontium ranelate (Protelos) is a drug approved for the treatment of osteoporosis in Europe, but not in Canada. It is effective in reducing fractures . Recently the European Medicines Agency […]

PROVINCIAL DRUG COVERAGE AS OF FEBRUARY 2024 Coverage is under constant review and is subject to change. Access to a generic equivalent is generally reported to be identical to that […]

Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]